Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra
NCT00159848
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Male subjects above age of majority for whom sildenafil is prescribed for the first time within the usual practice of medicine
- Male subjects who have used any ED medical treatments over the last month, with the
exception of testosterone and/or herbal therapies
- Subjects who do not have the possibility of viewing the video either through a
computer, VCR or a DVD
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Haifa,
- Amphion-Les-Bains,
- Bordeaux,
- La Rochelle,
- Lille,
- Lyon Cedex 03,
- Lyon,
- PARIS Cedex 13,
- Paris,
- Saint-Emilion,
- Thionville,
- Toulouse,
- Oslo,
- Belfast, Northern Ireland
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra | |||
Official Title ICMJE | Effectiveness Of An Educational Program To Improve Patients' Satisfaction Regarding Their Management Of Erectile Dysfunction With Sildenafil | |||
Brief Summary | This study will demonstrate if a treatment optimization program has an impact on the satisfaction with Viagra treatment in men with erectile dysfunction | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 4 | |||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Crossover Assignment Masking: None (Open Label) | |||
Condition ICMJE | Impotence | |||
Intervention ICMJE | Behavioral: Treatment Optimization Program (educational material) | |||
Study Arms ICMJE | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Enrollment ICMJE | 8000 | |||
Original Enrollment ICMJE | Same as current | |||
Actual Study Completion Date ICMJE | September 2003 | |||
Actual Primary Completion Date | September 2003 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | Not Provided | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00159848 | |||
Other Study ID Numbers ICMJE | NRA1481115 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Pfizer | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | May 2013 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |